Advanced Malignancies

Also known as: Advanced Malignancy

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB12603	AMG-208	1	Completed	1
DB15639	AMG-337	1	Completed	1
DB12729	ASP-3026	1	Completed	1
DB16412	Adebrelimab	1	Active Not Recruiting	1
DB16412	Adebrelimab	1	Recruiting	1
DB05220	Alisertib	1	Completed	2
DB16640	Almonertinib	1	Recruiting	1
DB00112	Bevacizumab	1	Completed	2
DB00188	Bortezomib	1	Completed	1
DB16741	Bortezomib D-mannitol	1	Completed	1
DB12109	CPI-613	1	Completed	1
DB15082	Cabiralizumab	1	Completed	1
DB01101	Capecitabine	1	Completed	1
DB00958	Carboplatin	1	Completed	1
DB14707	Cemiplimab	1	Completed	1
DB14707	Cemiplimab	1	Recruiting	1
DB14707	Cemiplimab	1	Withdrawn	1
DB00531	Cyclophosphamide	1	Completed	1
DB08912	Dabrafenib	1	Completed	1
DB01248	Docetaxel	1	Completed	1
DB11714	Durvalumab	1	Completed	1
DB06302	Glesatinib	1	Completed	2
DB13023	IPI-493	1	Terminated	1
DB06186	Ipilimumab	1	Recruiting	1
DB01167	Itraconazole	1	Active Not Recruiting	1
DB16679	Letaplimab	1	Completed	2
DB15768	MEDI0680	1	Completed	1
DB13061	MLN8054	1	Terminated	1
DB15299	Navtemadlin	1	Completed	3
DB09035	Nivolumab	1	Completed	1
DB01229	Paclitaxel	1	Completed	1
DB14867	Parsaclisib	1	Completed	1
DB14867	Parsaclisib	1	Recruiting	1
DB03010	Patupilone	1	Completed	4
DB03010	Patupilone	1	Terminated	1
DB09037	Pembrolizumab	1	Terminated	1
DB00642	Pemetrexed	1	Completed	1
DB12257	Platinum	1	Recruiting	1
DB01045	Rifampicin	1	Active Not Recruiting	1
DB00073	Rituximab	1	Not Yet Recruiting	1
DB14765	Rivoceranib	1	Terminated	1
DB00020	Sargramostim	1	Completed	1
DB15765	Sintilimab	1	Not Yet Recruiting	1
DB15765	Sintilimab	1	Recruiting	2
DB14892	Spartalizumab	1	Completed	1
DB12887	Tazemetostat	1	Active Not Recruiting	1
DB15043	Toripalimab	1	Active Not Recruiting	1
DB08911	Trametinib	1	Completed	2
DB08911	Trametinib	1	Recruiting	1
DB11771	Tremelimumab	1	Completed	1
DB04879	Vatalanib	1	Completed	1
DB05476	WX-UK1	1	Completed	1
DB05014	XL999	1	Completed	1
DB16834	AZD-7648	1 / 2	Recruiting	1
DB00928	Azacitidine	1 / 2	Terminated	2
DB00188	Bortezomib	1 / 2	Terminated	1
DB01101	Capecitabine	1 / 2	Unknown Status	1
DB08889	Carfilzomib	1 / 2	Terminated	1
DB01262	Decitabine	1 / 2	Active Not Recruiting	1
DB01234	Dexamethasone	1 / 2	Terminated	1
DB00997	Doxorubicin	1 / 2	Recruiting	1
DB11717	Epacadostat	1 / 2	Terminated	2
DB01590	Everolimus	1 / 2	Unknown Status	1
DB00441	Gemcitabine	1 / 2	Terminated	1
DB16054	INCB-057643	1 / 2	Terminated	1
DB06186	Ipilimumab	1 / 2	Completed	2
DB12154	Itacitinib	1 / 2	Terminated	1
DB00480	Lenalidomide	1 / 2	Terminated	1
DB09035	Nivolumab	1 / 2	Completed	2
DB01229	Paclitaxel	1 / 2	Terminated	1
DB14867	Parsaclisib	1 / 2	Terminated	1
DB09037	Pembrolizumab	1 / 2	Recruiting	2
DB09037	Pembrolizumab	1 / 2	Terminated	2
DB08910	Pomalidomide	1 / 2	Terminated	1
DB15185	Rasdegafusp alfa	1 / 2	Completed	1
DB06530	Resiquimod	1 / 2	Completed	1
DB16322	Sabatolimab	1 / 2	Active Not Recruiting	1
DB14892	Spartalizumab	1 / 2	Active Not Recruiting	1
DB11885	Anlotinib	2	Completed	1
DB09037	Pembrolizumab	2	Active Not Recruiting	1
DB15102	Pemigatinib	2	Active Not Recruiting	1
DB15766	Retifanlimab	2	Active Not Recruiting	1
DB15766	Retifanlimab	2	Not Yet Recruiting	1
DB06398	Tanespimycin	2	Completed	1
DB11945	Avelumab	3	Recruiting	1
DB06626	Axitinib	3	Recruiting	1
DB12267	Brigatinib	3	Completed	1
DB01101	Capecitabine	3	Enrolling by Invitation	1
DB08865	Crizotinib	3	Completed	1
DB00441	Gemcitabine	3	Terminated	1
DB16208	Ivuxolimab	3	Recruiting	1
DB14769	Pamiparib	3	Enrolling by Invitation	1
DB00642	Pemetrexed	3	Enrolling by Invitation	1
DB00642	Pemetrexed	3	Recruiting	1
DB11760	Talazoparib	3	Recruiting	1
DB00853	Temozolomide	3	Enrolling by Invitation	1
DB14922	Tislelizumab	3	Enrolling by Invitation	1
DB15113	Utomilumab	3	Recruiting	1
DB12267	Brigatinib	Not Available	No Longer Available	1
DB05014	XL999	Not Available	No Longer Available	1